红金消结胶囊治疗麦默通微创旋切术后血肿的临床观察  

Clinical observation of HongjinXiaojie capsule in the treatment of hematomas after minimally invasive vacuum-assisted Mammotome mastectomy

作　　者：孙云芸 闵美林[1] 许丽波 SUN Yunyun;MIN Meilin;XU Libo(Department of Thyroid and Breast,Wuxi Traditional Chinese Medicine Hospital,Wuxi 214000,China;Department of Ultrasound,Wuxi Traditional Chinese Medicine Hospital,Wuxi 214000,China)

机构地区：[1]无锡市中医医院甲乳科,214000 [2]无锡市中医医院超声科,214000

出　　处：《天津医药》2025年第4期389-392,共4页Tianjin Medical Journal

基　　金：2023年无锡市中医药管理局项目(ZYYB08)。

摘　　要：目的通过观察红金消结胶囊治疗麦默通微创旋切术后血肿的疗效,以期确定麦默通微创旋切术后常见的血肿和疼痛等临床并发症的治疗方法。方法选取在我院行乳房肿块麦默通微创旋切术,术后72 h形成血肿患者70例。按治疗方法不同,将患者分为观察组及对照组各35例,对照组予单纯热敷外治,观察组予局部热敷及口服红金消结胶囊治疗4周,术后每4周随访1次,连续随访12周,复查彩超观察血肿大小。比较2组随访期间疼痛视觉模拟量表(VAS)评分和气滞血瘀中医证候积分变化。结果术后4周,观察组疼痛VAS评分明显低于对照组[(2(1,3)分vs.3(2,4)分,P<0.05)],血肿比例低于对照组(45.7%vs.82.9%,P<0.05)。术后12周,2组疼痛VAS评分及血肿比例差异无统计学意义。术后4周及12周观察组中医症候积分均低于对照组(P<0.05)。结论红金消结胶囊可促进麦默通术后血肿吸收,有效缓解乳房疼痛,安全性较高,具有临床推广价值。Objective To observe the efficacy of Hongjin Xiaojie capsules in treating hematoma after Mammotome minimally invasive excision and to determine the common clinical complications such as hematoma and pain after the surgery.Methods A total of 70 patients who developed hematoma within 72 hours after Mammotome minimally invasive excision for breast lumps at our hospital were selected.Based on different treatment methods,patients were divided into the observation group and the control group,with 35 cases in each group.The control group received only external hot compress treatment,while the observation group received local hot compress combined with oral administration of Hongjin Xiaojie Capsule for 4 weeks.Follow-up was conducted every 4 weeks postoperatively for a total of 12 weeks.Color ultrasound was performed to monitor the size of the hematoma.Changes in pain visual analog scale(VAS)scores and traditional Chinese medicine(TCM)syndrome scores for blood stasis were compared between the two groups of patients during follow-up.Results Four weeks after operation,the pain VAS score was significantly lower in the observation group than that in the control group[2(1,3)points vs.3(2,4)points,P<0.05],and the proportion of hematoma was lower in the observation group than that in the control group(45.7%vs.82.9%,P<0.05).At 12 weeks after surgery,there were no significant differences in pain scores or hematoma proportions between the two groups.The TCM symptom scores were lower in the observation group than those of the control group at 4 weeks and 12 weeks after operation(P<0.05).Conclusion Hongjin Xiaojie capsule can promote the absorption of hematoma after Mammotome surgery,effectively alleviate breast hematoma and pain,and have high safety,demonstrating broad clinical application value.

关 键 词：乳房 血肿 麦默通微创旋切术 红金消结胶囊 吸收与散瘀 

分 类 号：R271.44[医药卫生—中医妇科学] R655.82[医药卫生—中医学]